drugset / Trial / NCT01409603

To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects

NCT01409603

Phase 1 Completed 26 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The primary objective of this study is to evaluate whether naproxen and darexaban which have different effects on blood coagulation influence each other in their effects. Also it will be investigated whether the blood levels of either drug are influenced by the presence of the other drug. In addition, the safety and tolerability of each drug and the combination of the drugs will be investigated.

Timeline

Start
2010-01
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule Oral
Subject darexaban Small molecule Oral

Indications

No indication recorded.